-
“During my Senate service, I fought diligently to combat the deadly opioid epidemic. Yet much work remains to be done,” said Orrin G. Hatch, Chairman Emeritus of the Hatch Foundation. No Mr. Hatch as a US Senator
-
On October 5, 2019, in U.S. Bankruptcy Court, Southern District of NY a Chapter 11 filing against Purdue Pharma, maker of OxyContin was entered. A definition of Chapter 11 bankruptcy is that it involves a reorganization of
-
In the last couple of months, I have been researching the agendas of some self-proclaimed “harm reduction promoters” in the raging opioid/drug epidemic destroying families in the hundreds of thousands. What has
-
“Carve your name on hearts, not tombstones. A legacy is etched into the minds of others and the stories they share about you.” ~ Shannon L. Alder A recent article in the “Washington Post” exposes the criminal
-
Anyone questioning how the U.S. has become a killing field in the opioid/drug epidemic going back randomly to 1999? Let me break it down for you in simplified terms taken from the National Register as follows: In 1999, the
-
On July 16, “The Washington Post” published a “breaking” article on 76 billion opioid pills unmasking the epidemic. Further, they stated that in the many lawsuits filed across the country against the
-
(MYRTLE BEACH) I recently sent the below email to Mike Moore, attorney of tobacco industry multi-billion dollar settlement fame, now tackling the pharmaceutical industry in the opioid crisis crippling every state in the
-
His "guide" aimed at State Medical Boards around the country became the holy grail to physicians in minimizing the dangers of addiction and death from prescribed opioids such as OxyContin.
-
Do you think it is time to stop idolizing the "wannabe rock star advocates" and work on prevention, education and treatment like your child's life depends on it? Can a focus be put on "harm elimination" rather than "harm
-
I want to know why the Sackler family has not been held accountable for their involvement with Purdue Pharma and the mass marketing of OxyContin.
